Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PKR activator 3
Cat. No.:
OB0425LY-252
Appearance:
Solid
Purity:
99.87%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
PKR activator 3 is a small molecule compound primarily used to activate protein kinase R (PKR).
Synonyms:
1628428-01-2; N-[4-[4-Hydroxy-4-(2-methylpropyl)piperidine-1-carbonyl]phenyl]quinoxaline-5-sulfonamide; 5-Quinoxalinesulfonamide, N-(4-((4-hydroxy-4-(2-methylpropyl)-1-piperidinyl)carbonyl)phenyl)-; N-(4-((4-Hydroxy-4-(2-methylpropyl)-1-piperidinyl)carbonyl)phenyl)-5-quinoxalinesulfonamide
CAS No.:
1628428-01-2
Compound CID:
86295470
Formula:
C24H28N4O4S
Formula Weight:
468.57
Specification
Target:
Pyruvate kinase
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
PKR activator 3 can be used to study diseases related to PKR function, including cancer, diabetes, and obesity.
